Sigma Planning Corp
TGTX icon

Sigma Planning Corp’s TG Therapeutics TGTX Stock Holding History

Sigma Planning Corp’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$568K Sell
10,175
-5,200
-34% -$281K 0.01% 793
2026
Q2 		$845K Buy
+15,375
New +$629K 0.02% 673
2025
Q3 		– Sell
-35,227
Closed -$1.27M – 1376
2025
Q2 		$1.27M Buy
35,227
+3,472
+11% +$129K 0.04% 426
2025
Q1 		$1.25M Buy
+31,755
New +$1.07M 0.04% 410

Other funds holding TGTX

Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Mutual of America Capital Management
Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return
Quantum Private Wealth
Quantum Private Wealth Tampa, Florida $391M AUM 50.76% 1-Year Est. Return
Louisiana State Employees Retirement System
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Yousif Capital Management
Yousif Capital Management Bloomfield Hills, Michigan $8.87B AUM 34.1% 1-Year Est. Return
Amalgamated Bank
Amalgamated Bank New York $14.3B AUM 35.81% 1-Year Est. Return
Tealwood Asset Management
Tealwood Asset Management Minneapolis, Minnesota $251M AUM 42.58% 1-Year Est. Return

Sigma Planning Corp's TGTX Position: Q3 2026 in Review

Sigma Planning Corp reduced its TG Therapeutics (TGTX) stake by 34% in Q3 2026, selling an estimated $281K and leaving 10,175 shares worth $568K. The position accounts for 0.01% of the portfolio, ranked #793.

Sigma Planning Corp first reported a position in TGTX in Q1 2025 and has held it in 4 quarters since. The position peaked at $1.27M in Q2 2025. 84 funds tracked by Wall St. Rank hold TGTX as of Q3 2026.

  • Sigma Planning Corp held 10,175 shares of TG Therapeutics worth $568K as of Q3 2026.
  • Sigma Planning Corp sold 5,200 TG Therapeutics shares in Q3 2026, an estimated $281K.
  • TG Therapeutics made up 0.01% of Sigma Planning Corp's portfolio in Q3 2026, its #793 holding.
  • Sigma Planning Corp first reported a position in TG Therapeutics in Q1 2025 and has held it in 4 quarters since.
  • Sigma Planning Corp's TG Therapeutics position peaked at $1.27M in Q2 2025.
  • 84 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2026.

Based on Sigma Planning Corp's 13F filing for Q3 2026, filed 23 Oct 2026.